Interphex Puerto Rico, the annual event that gathers key components of the island’s knowledge-based economy, will again offer an agenda full of conferences and training sessions Oct. 20-21 that focus on its mission to generate activity and help professionals move forward.
The Puerto Rico Pharmaceutical Industry Association raised three specific objections to the recently released study evaluating quality results in drug manufacturing plants outside the U.S. mainland, saying, among other things, the findings were “highly questionable.”
Drugs produced in U.S.-owned and operated pharmaceutical manufacturing plants in Puerto Rico are more likely to have quality problems than those produced by the same firm in a matched plant on the mainland, a study released Tuesday by Ohio State University's Fisher College of Business.
A Dow Jones/Factiva content provider since 2014
Subscribe to our Dollars & Sense podcast!
